Semintra® (telmisartan) is an angiotensin receptor inhibitor used to treat chronic kidney disease in cats, requiring regular veterinary monitoring.
Form
Semintra® contains telmisartan, an angiotensin receptor inhibitor that reduces protein loss in the urine of cats with [chronic kidney disease](https://monvet.com/en/chronic-kidney-disease-cats/). It is not suitable for pregnant females, animals under 9 months old, or those suffering from acute or chronic kidney, heart, or liver diseases. Side effects include low blood pressure, vomiting, and digestive issues. Veterinary monitoring helps track kidney and liver function. Store it at room temperature and use it within six months after opening to ensure its effectiveness.
Telmisartan
Room temperature
Regular veterinary monitoring is essential to track kidney and liver function, blood pressure, and the presence of proteins in the urine.
Digoxine
Semintra® is contraindicated in pregnant or lactating females, animals under 9 months old, and those with hypersensitivity to telmisartan or its excipients. It should not be used in cats with acute kidney disease, dehydration, diabetes, or heart and liver conditions.
- Low blood pressure - Vomiting - Diarrhea - Soft stools - Digestive ulcers - Anemia - Liver issues (reversible after stopping treatment)
Sélectionner votre vétérinaire pour être redirigé à sa boutique en ligne.
Select your veterinarian to be redirected to their online store.